The Journal Review of Clinical Pharmacology and Pharmacokinetics-International Edition (abbreviated title: Rev. Clin. Pharmacol. Pharmacokinet., Int. Ed.) founded in 1987 aims to promote optimum drug therapy by providing original papers and review articles covering important aspects of clinical and applied Pharmacology and Therapeutics. It also covers important areas in Medicine. It became an open access journal in September 2023.
The Journal includes drug evaluation reviews providing a detailed focus on different properties, i.e. dosage, toxicology, drugs interactions and place in therapy of both newer and established drugs. Other Review Articles offer state-of-the-art literature surveys covering broader topics. Practical Therapeutics Articles and Leading Articles provide recommendations for specific situations of connections or emerging areas, respectively. The journal publishes:
Original papers/ Research Articles/ Review articles/ Case studies/ Clinical studies/ Literature reviews/ Statistical studies
The Journal publishes, in special issues, papers presented at:
- the Panhellenic Congresses of Pharmacology organized by the Hellenic Society of Pharmacology,
- the Conferences with International Participation Medicinal Chemistry: Drug Discovery and Design organized by the Departments of Chemistry and Pharmacy of the University of Patras, Hellas
- Proceedings of PanHellenic Congress of Aesthetics and Cosmetology (Cosmoestetica)
- the Proceedings of the 1stGreek Scientific Society of Cosmetology Conference
- the Proceedings of the 1 stInternational Babylon Conference on Clinical and Experimental Pharmacological Research
The articles must not have been published in Greek or International Journals.
Submitted articles must be accompanied by a signed consent form from all authors. The corresponding author is responsible for the collection of all signed forms by the authors and their submission to the journal Editor-In-Chief prior to publication.
The scientific standard of the papers, which are accepted for publication, is controlled by the Editorial Board or by other Experts in the various fields of Pharmacology, Pharmacokinetics and Therapeutics and Medicine.
Submitted papers are subject to a rigorous but rapid peer review process. A first decision is provided to authors approximately in a week after submission and we aim for a review time of two weeks. Acceptance for publication is approximately in 4-8 weeks. Faster Publication in PHARMAKON- PRESS open access journal is achieved by online availability.
The review process is designed to help authors to improve their articles by giving them constructive comments, and we select to publish only those articles which comply to general quality criteria of a scholarly paper, especially originality, clarity, references to related work and validity of results and conclusions.